title: Bone density testing: science, the media, and patient care.
abstract: Dual-energy X-ray absorptiometry (DXA) is an inexpensive, noninvasive, widely available method for diagnosing osteoporosis, assessing fracture risk, and monitoring the effects of therapy. By diagnosing high-risk patients before a fracture occurs, clinicians can intervene early to reduce fracture risk. Appropriate use of DXA results in money saving for healthcare systems that might otherwise be spent for fracture-related care. Recent reports of studies evaluating DXA screening criteria and intervals for retesting have received considerable media coverage, sometimes suggesting that DXA is expensive, over-utilized, and unnecessary. This may lead to more patients who might benefit from early detection of osteoporosis remaining undiagnosed. We advocate for the use of current clinical practice guidelines with individualization of patient care factors to determine the optimal intervals for DXA testing.
authors.forename: Micol S
authors.initials: MS
authors.lastname: Rothman
authors.forename: Paul D
authors.initials: PD
authors.lastname: Miller
authors.forename: E  Michael
authors.initials: E
authors.lastname: Lewiecki
authors.forename: John P
authors.initials: JP
authors.lastname: Bilezikian
mesh_terms: D015502:Absorptiometry, Photon / Q000706:statistics & numerical data*; D015519:Bone Density; D006801:Humans; D008402:Mass Media; D008403:Mass Screening / Q000706:statistics & numerical data*; D010024:Osteoporosis / Q000175:diagnosis / Q000000981:diagnostic imaging*; D017410:Practice Guidelines as Topic